Cytosorbents Cor (CTSO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 41,005 | 24,950 | 22,504 | 15,151 | 9,528 |
| Cost of Goods | 11,052 | 7,364 | 7,489 | 5,518 | 3,954 |
| Gross Profit | 29,952 | 17,586 | 15,015 | 9,632 | 5,574 |
| Operating Expenses | 40,375 | 36,924 | 31,089 | 19,993 | 18,020 |
| Operating Income | -10,370 | -18,974 | -15,585 | -9,843 | -11,492 |
| Other Income | 1,406 | -1,384 | -2,246 | 705 | -590 |
| Pre-tax Income | -8,964 | -20,358 | -17,831 | -9,138 | -12,082 |
| Income Tax | -1,127 | -1,092 | -620 | -677 | -319 |
| Net Income Continuous | -7,837 | -19,266 | -17,211 | -8,461 | -11,764 |
| Net Income | $-7,837 | $-19,266 | $-17,211 | $-8,461 | $-11,764 |
| EPS Basic Total Ops | -0.20 | -0.60 | -0.56 | -0.32 | -0.46 |
| EPS Basic Continuous Ops | -0.20 | -0.60 | -0.56 | -0.31 | -0.46 |
| EPS Diluted Total Ops | -0.20 | -0.60 | -0.56 | -0.32 | -0.46 |
| EPS Diluted Continuous Ops | -0.20 | -0.60 | -0.56 | -0.31 | -0.46 |
| EPS Diluted Before Non-Recurring Items | -0.20 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-9,387 | $-18,277 | $-15,097 | $-9,542 | $-11,300 |